Core Laboratories Inc (CLB)

EBITDA Margin

12.07%

TTM · Period ending:

CLB logo

CLB EBITDA Margin

Latest reported12.07%
CLB TTM EBITDA Margin (54.13% → 12.07%)
High-resolution chart · PNG

CLB ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Core Laboratories Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
12.0669%
13.0798%
13.507%
13.4212%
13.2228%
13.3699%
14.0325%
14.2387%
13.5402%
14.0984%
13.7633%
13.9611%
13.9862%
13.1605%
12.2129%
11.8226%
10.2186%
10.0453%
12.8144%
13.3552%
15.1466%
12.264%
-13.4762%
-10.8598%
-6.2162%
-0.9585%
17.852%
17.0014%
17.3091%
17.9389%
19.3896%
21.5428%
21.021%
20.8461%
20.8212%
19.9147%
19.781%
18.8462%
19.0084%
18.4211%
20.7107%
22.9187%
23.6392%
28.5626%
30.5898%
32.1489%
34.3918%
34.2165%
33.8832%
33.779%
33.4315%
32.8739%
32.8356%
31.8027%
31.5323%
31.6039%
30.7552%
30.5197%
30.0983%
30.0301%
30.7125%
30.5376%
30.674%
29.5821%
27.9717%
28.9389%
27.816%
27.6643%
27.8331%
27.8607%
28.2237%
30.3288%
30.43%
29.0533%
28.1585%
25.6909%
24.7489%
24.8158%
23.4663%
20.7578%
18.0241%
15.0113%
13.5323%
13.5538%
14.5919%
14.4202%
14.9979%
15.2438%
15.2792%
15.2586%
14.0535%
10.3699%
9.5249%
9.6942%
10.7896%
12.1454%
14.1762%
15.4757%
16.5729%
18.67%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.